Effect of recombinant human erythropoietin on the platelet function of hemodialysis patients

Effect of recombinant human erythropoietin on the platelet function of hemodialysis patients

The effect of recombinant human erythropoietin (rEPO) on platelet function was evaluated in 18 long-term hemodialysis patients (age 45.4±15.4 years, M/F 8/10, HD history 85.4±48.0 months). 3, 000U/HD of rEPO were injected via the venous line of an extracorporeal circuit at the end of each hemodialys...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Japanese Society for Dialysis Therapy 1990/10/28, Vol.23(10), pp.1113-1116
Hauptverfasser: Matsui, Noriaki, Kimoto, Sigeaki, Goto, Ken, Shinohara, Shinsuke, Akiba, Takasi, Marumo, Humiaki
Format: Artikel
Sprache:jpn
Schlagworte:
recombinant human erythropoietin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The effect of recombinant human erythropoietin (rEPO) on platelet function was evaluated in 18 long-term hemodialysis patients (age 45.4±15.4 years, M/F 8/10, HD history 85.4±48.0 months). 3, 000U/HD of rEPO were injected via the venous line of an extracorporeal circuit at the end of each hemodialysis. Ht increased 18.8±3.0 to 32.9±3.1%. Platelet count did not change significantly. Platelet retention increased markedly 3.0±3.6 to 11.9±9.1% (p
ISSN:0911-5889
1884-6211
DOI:10.4009/jsdt1985.23.1113